Ivan Bergstein, Chief Executive Officer at STEMLINE THERAPEUTICS INC (STML), sold 107,236 shares at $4.88 ($523K) on 2020-04-15, disclosed to the SEC on 2020-04-20.
Open-market sale of $523k STML by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.88 | 53,618 | $262K | 50.0% |
| 2 | $4.88 | 53,618 | $262K | 50.0% |
| Total | $4.88 avg | 107,236 | $523K | 100% |
| Filing → |
| STML | SELL | 2020-01-03 | $987K | — | Filing → |
| STML | SELL | 2019-08-16 | $1.0M | — | Filing → |
| STML | SELL | 2019-06-28 | $1.3M | — | Filing → |